Professor Pieter Kamphuisen
Hilversum (Netherlands (The))
How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?
Event: ESC Congress 2018
Topic: Atrial Fibrillation (AF)
Session: Biomarker-based approaches for improved atrial fibrillation management
Practical guidance for patient-protection in the era of NOACs.
Event: ESC CONGRESS 2014
Topic: Thrombosis and coagulation
Session: Changing the face of anticoagulation: 5 years since RE-LY®
ESC 365 is supported by
